PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV

Wegovy & Ozempic: The Ins & Outs of Weight Loss Drugs | Mark Moyad, MD & Mark Scholz, MD | PCRI

7:20Jul 2022

Today’s cheapest semaglutide$39/mo at Wellmedr, sale price.Compare all semaglutide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

In this short conversation, the speaker, MD and the speaker, MD discuss the GLP-1 agonist class of weight loss drugs. The speaker says Wegovy, also known as semaglutide, is the first of the class to be approved for weight loss, and that a second drug with a dual action is on the way. He says initial gastrointestinal side effects can occur, but that clinical trial participants often lose 10 to 20 percent of body weight in six to 12 months, which he compares to bariatric surgery.

Published by Prostate Cancer Research Institute on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

The doctors name three obstacles. According to the speaker, the drugs are very expensive, they are hard to get because of demand and a manufacturing problem, and many people do not realize the same compound already exists at lower doses for type 2 diabetes, as Ozempic and the tablet Rybelsus. Another speaker describes patients in his practice, including a man who had struggled with weight for 25 years, lost about 20 pounds, lost interest in eating, and reported no side effects. He says Ozempic was approved for adult onset diabetes and has been used off label for weight loss.

Both stress that this is not magic. The speaker says the drugs work by reducing the desire to eat, so people still have to eat less, as with bariatric surgery. He hopes more manufacturers, including Eli Lilly, will bring prices down. He also says he hopes long-term effectiveness and safety hold up, and that the cost and the need to stay on the drug long term remain open issues.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:05 The speaker introduces GLP-1 agonists, with Wegovy (semaglutide) as the first approved for weight loss and another dual-action drug coming.
  2. 0:35 He says trial participants often lose 10 to 20 percent of body weight in six to 12 months, comparable to bariatric surgery for many people.
  3. 1:06 He lists the catches: high cost, limited supply from demand and manufacturing problems, and the existence of lower-dose versions (Ozempic, Rybelsus) for type 2 diabetes.
  4. 2:19 Another speaker describes a patient who lost about 20 pounds after 25 years of trying, with less interest in food and no side effects.
  5. 4:43 The speaker says the drugs work by reducing the desire to eat, so people still need to eat less.
  6. 6:15 Both doctors say they hope long-term effectiveness and safety hold up, and that cost and staying on the drug long term are open questions.

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic and Wegovy

Questions this video answers

How much weight can people lose on Wegovy?

The speaker says people in clinical trials often lose 10 to 20 percent of their body weight in six to 12 months. He compares this to the effect of bariatric surgery for many people.

How do GLP-1 weight loss drugs work according to these doctors?

The speaker says the drugs reduce the desire to eat large quantities of food. He says they are not magic and, like bariatric surgery, still depend on people eating less.

What is the difference between Wegovy, Ozempic and Rybelsus?

According to the speaker, they are the same compound, semaglutide. Ozempic is a lower dose used for type 2 diabetes, and Rybelsus is a tablet form, while Wegovy is the version approved for weight loss.

What are the downsides of these weight loss drugs mentioned in the video?

The doctors mention high prices, limited availability because of demand and a manufacturing issue, and some initial gastrointestinal side effects such as nausea. They also say long-term effectiveness and safety still need to be confirmed and that people may need to stay on the drug long term.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Semaglutide for weight loss: which version, and what each costs

    Semaglutide is the molecule. For weight loss the FDA-approved version is Wegovy, sold as a weekly pen and a daily tablet. Ozempic is the same molecule approved for type 2 diabetes, so using it for weight is off-label. Compounded semaglutide uses semaglutide as its active ingredient, comes from a compounding pharmacy, is not FDA-approved, and is what most cash buyers actually take because it costs a fraction of the brand. All three produce the same side effects. What differs is the approval, the oversight and the price.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

  • The best GLP-1 for weight loss, ranked by the evidence and then by the bill

    By weight lost, the order is settled: tirzepatide (Zepbound) first at 20.2% in the only head-to-head, then semaglutide 7.2 mg (Wegovy HD) at 18.7%, then semaglutide 2.4 mg (Wegovy) at 13.7% to 15.6%, then the pills. By what you pay, the order nearly inverts: compounded semaglutide from $39 a month, the Wegovy tablet from $149, Wegovy pen $349, Zepbound $299 to $699 by dose. The best one is where those two lists meet for your budget and your plan.

Next steps

Ozempic prices

Insurance

Find more like it

Side effects

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV